AngioDynamics (NASDAQ:ANGO) Rating Reiterated by HC Wainwright

HC Wainwright restated their buy rating on shares of AngioDynamics (NASDAQ:ANGO – Free Report) in a research report report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $14.00 target price on the medical instruments supplier’s stock. HC Wainwright also issued estimates for AngioDynamics’ Q4 2024 earnings at ($0.21) EPS, Q2 2025 earnings […]

Related Keywords

United States ,Jamesc Clemmer , ,Angiodynamics Company Profile ,Securities Exchange Commission ,Angiodynamics Inc ,Acadian Asset Management ,Acuitas Investments ,Sg Capital Management ,Jacobs Levy Equity Management Inc ,Free Report ,Moderate Buy ,Get Free Report ,Exchange Commission ,Asset Management ,Jacobs Levy Equity Management ,Levy Equity Management ,Auryon Atherectomy ,Angiodynamics Daily ,